Chiron Real Estate Inc. (NYSE: XRN) is a Real Estate company in the REIT - Healthcare Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
Latest market price
35.90
-0.17-0.47%
TA
Loading chart...
Snapshot
| Index | - | P/E | 9.69 | EPS (ttm) | 3.72 | Insider Own | 4.96% | Shs Outstand | 13.23M | Perf Week | 1.61% |
| Market Cap | 477.38M | Forward P/E | - | EPS next Y | -2.29 | Insider Trans | 2.80% | Shs Float | 12.30M | Perf Month | -0.91% |
| Enterprise Value | 466.72M | PEG | - | EPS next Q | - | Inst Own | - | Short Float | 6.67% | Perf Quarter | 11.67% |
| Income | 54.95M | P/S | 3.05 | EPS this Y | 22.77% | Inst Trans | - | Short Ratio | 5.59 | Perf Half Y | -1.74% |
| Sales | 156.77M | P/B | 0.73 | EPS next Y | -164.74% | ROA | 4.01% | Short Interest | 820.89K | Perf YTD | - |
| Book/sh | - | P/C | 6.39 | EPS next 5Y | - | ROE | 10.22% | 52W High | 38.47 -6.68% | Perf Year | - |
| Cash/sh | - | P/FCF | 18.76 | EPS past 3/5Y | - | ROIC | 19.22% | 52W Low | 28.91 24.17% | Perf 3Y | - |
| Dividend Est. | 0.64 (1.78%) | EV/EBITDA | 7.49 | Sales past 3/5Y | 5.53% 11.36% | Gross Margin | 0.92% | Volatility | 2.74% 2.57% | Perf 5Y | - |
| Dividend TTM | 2.57 (7.16%) | EV/Sales | 2.98 | EPS Y/Y TTM | -461.29% | Oper. Margin | 19.62% | ATR (14) | 0.98 | Perf 10Y | - |
| Dividend Ex-Date | Aug 20, 2026 | Quick Ratio | 0.00 | Sales Y/Y TTM | 14.49% | Profit Margin | 35.06% | RSI (14) | 47.13 | Recom | 2.60 |
| Dividend Gr. 3/5Y | -7.72% -3.77% | Current Ratio | 0.00 | EPS Q/Q | -137.73% | SMA20 | -1.58% | Beta | 0.45 | Target Price | 40.33 |
| Payout | 99.33% | Debt/Eq | 0.00 | Sales Q/Q | 0.00% | SMA50 | -1.20% | Rel Volume | 0.59 | Prev Close | 36.07 |
| Employees | 30 | LT Debt/Eq | 1.25 | Earnings | Nov 03 | SMA200 | 1.27% | Avg Volume | 136.39K | Price | 35.90 |
| IPO Date | Jun 29, 2016 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -1232.00% -0.50% | Net Debt/EBITDA | -0.17 | Volume | 80,821 | Change | -0.47% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jul-01-26 | Reiterated | Industrial Alliance Securities | $40 → $43 | |
| May-18-26 | Reiterated | BMO Capital | Market Perform | $39 |
| May-07-26 | Reiterated | Industrial Alliance Securities | $42 → $40 | |
| May-07-26 | Downgrade | Compass Point | Buy → Neutral | $38 |
| Oct-13-25 | Upgrade | JMP Securities | Market Perform → Market Outperform |
Latest News
Aug-06-26
Aug-05-26
Aug-05-2604:05PM
Aug-04-26
Aug-04-2601:59AM
Aug-03-26
Aug-03-2604:07PM
04:05PM
Jul-27-26
Jul-16-26
Jul-16-2604:05PM
Jul-14-26
Jul-14-2604:05PM
Jul-13-26
Jul-13-2607:43AM
Jul-06-26
Jul-06-2606:08AM
Jun-30-26
Jun-30-2609:22AM
Jun-24-26
Jun-23-26
Jun-18-26
Jun-18-2601:27AM
Jun-17-26
Jun-17-2610:21AM
Company
Global Medical REIT, Inc. focuses on acquiring specialized healthcare properties designed for medical purposes, subsequently renting them out to medical systems and physician practices. The company was established on March 18, 2011, and operates primarily from its headquarters in Bethesda, Maryland.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 157 | 161 | 138 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 115 | 151 | 29 | — | — | — | — | — | — | |
| Gross Profit | 1 | 10 | 109 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 29 | 20 | 21 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | — | |
| Other Operating Expense | -48 | -59 | 55 | — | — | — | — | — | — | |
| Operating Income | 30 | 49 | 33 | — | — | — | — | — | — | |
| Interest Expense | 36 | 45 | 29 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 59 | -12 | 3 | — | — | — | — | — | — | |
| Net Income Before Taxes | 54 | -7 | 7 | — | — | — | — | — | — | |
| Income Taxes | 0 | 0 | 0 | — | — | — | — | — | — | |
| Consolidated Net Income | 54 | -6 | 7 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 54 | -7 | 7 | — | — | — | — | — | — | |
| Net Income | 54 | -6 | 7 | — | — | — | — | — | — | |
| EPS (Recurring) | 3.72 | -0.91 | 0.31 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 3.72 | -0.91 | 0.31 | — | — | — | — | — | — | |
| EPS (Diluted) | 3.72 | -0.91 | 0.31 | — | — | — | — | — | — | |
| EBITDA | 62 | 97 | 91 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 9.65 | — | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 2.97 | — | — | — | — | — | — | — | — | |
| Gross Margin | 0.64 | 6.21 | 78.99 | — | — | — | — | — | — | |
| Operating Margin | 19.11 | 30.43 | 23.91 | — | — | — | — | — | — | |
| Net Margin | 34.39 | -3.73 | 5.07 | — | — | — | — | — | — | |
| Shares Outstanding | 13 | 13 | 3 | — | — | — | — | — | — | |
| Market Capitalization | 467 | — | — | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Cypher Matthew | Director | May 14 '26 | Buy | 35.12 | 1,420 | 49,874 | 1,690 | May 15 |
| Wittman Lori | Director | May 12 '26 | Buy | 33.85 | 2,940 | 99,515 | 2,940 | May 13 |
| Marston Ronald | Director | May 12 '26 | Buy | 34.07 | 1,500 | 51,111 | 3,066 | May 13 |
| Barber Jamie Allen | General Counsel and Secretary | May 12 '26 | Buy | 33.50 | 1,481 | 49,614 | 1,481 | May 13 |
| Holley Danica | COO | May 12 '26 | Buy | 33.99 | 1,490 | 50,645 | 1,590 | May 12 |
| Decker Mark Okey Jr | CEO and President | May 12 '26 | Buy | 33.94 | 5,000 | 169,700 | 59,774 | May 12 |
| KIERNAN ROBERT J | CFO and Treasurer | May 11 '26 | Buy | 33.49 | 3,000 | 100,470 | 6,000 | May 12 |
| Crowley Paula | Director | May 11 '26 | Buy | 34.00 | 1,000 | 34,000 | 1,000 | May 11 |
| Cole Henry | Director | May 11 '26 | Buy | 34.30 | 583 | 19,998 | 2,129 | May 11 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.